White House Opioid Report Urges Better Access To Overdose Treatment; Mandatory Prescriber Education
Pricing of anti-addiction therapies could come under more pressure from HHS if Trump Administration accepts White House commission recommendation to declare public health emergency on opioid crisis.
You may also be interested in...
Trump's Opioid Commission Asks FDA To Boost Post-Market Vigilance
Pharma is criticized for aggressive marketing, but the report also seeks industry help in research on innovative medication.
Opioid Abuse: The Limits Of Industry’s Response
PhRMA is endorsing dispensing limits on opioids and pledging to support a public/private partnership to develop new treatments and alternatives. But members of a Presidential Commission didn’t seem impressed.
FDA's Opioid Programs: After Training, What's The Next Step?
Treatment guidelines may also appear in opioid labeling, and insurers seem to be taking the agency's advice, but will it be enough to satisfy Congress?